Cabaletta Bio Financials
CABA Stock | USD 13.32 0.02 0.15% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Debt Equity Ratio | 0.0387 | 0.0212 |
|
| |||||
Current Ratio | 22.67 | 15.2864 |
|
|
The financial analysis of Cabaletta Bio is a critical element in measuring its lifeblood. The essential information of the day-to-day investment outlook for Cabaletta Bio includes many different criteria found on its balance sheet. For example, investors should never minimize Cabaletta Bio's ability to pay suppliers or employees on time, making sure interest payments are not accumulating or correctly timing where and how to re-invest extra cash. Any individual investor needs to monitor Cabaletta Bio's cash flow, debt, and profitability to effectively and accurately make more informed decisions on whether to invest in Cabaletta Bio.
Net Income |
|
With this module, you can analyze Cabaletta financials for your investing period. You should be able to track the changes in Cabaletta Bio individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Cabaletta | Select Account or Indicator |
Understanding current and past Cabaletta Bio Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Cabaletta Bio's financial statements are interrelated, with each one affecting the others. For example, an increase in Cabaletta Bio's assets may result in an increase in income on the income statement.
The data published in Cabaletta Bio's official financial statements usually reflect Cabaletta Bio's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Cabaletta Bio. For example, before you start analyzing numbers published by Cabaletta accountants, it's critical to develop an understanding of what Cabaletta Bio's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Cabaletta Bio's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Cabaletta Bio's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Cabaletta Bio's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Cabaletta Bio. Please utilize our Beneish M Score to check the likelihood of Cabaletta Bio's management manipulating its earnings.
Cabaletta Bio Stock Summary
Cabaletta Bio competes with Revolution Medicines, Black Diamond, Passage Bio, 89bio, and Madrigal Pharmaceuticals. Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Cabaletta Bio, Inc. was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania. Cabaletta Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 57 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US12674W1099 |
CUSIP | 12674W109 |
Location | Pennsylvania; U.S.A |
Business Address | 2929 Arch Street, |
Sector | Biotechnology |
Industry | Health Care |
Benchmark | NYSE Composite |
Website | www.cabalettabio.com |
Phone | 267 759 3100 |
Currency | USD - US Dollar |
You should never invest in Cabaletta Bio without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Cabaletta Stock, because this is throwing your money away. Analyzing the key information contained in Cabaletta Bio's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Cabaletta Bio Key Financial Ratios
Generally speaking, Cabaletta Bio's financial ratios allow both analysts and investors to convert raw data from Cabaletta Bio's financial statements into concise, actionable information that can be used to evaluate the performance of Cabaletta Bio over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Cabaletta Bio reports annually and quarterly.Return On Equity | -0.4 | ||||
EBITDA | (73.23 M) | ||||
Net Income | (67.67 M) |
Cabaletta Bio Key Balance Sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 141.5M | 114.7M | 126.3M | 117.0M | 253.7M | 266.3M | |
Other Current Liab | 2.2M | 3.9M | 6.0M | 4.8M | 7.9M | 4.0M | |
Net Tangible Assets | 138.3M | 109.5M | 116.6M | 104.5M | 120.2M | 84.0M | |
Net Debt | (136.2M) | (101.4M) | (122.2M) | (76.5M) | (188.2M) | (178.8M) | |
Retained Earnings | (33.0M) | (66.3M) | (112.6M) | (165.6M) | (233.2M) | (221.6M) | |
Accounts Payable | 920K | 1.2M | 2.3M | 2.5M | 4.5M | 4.8M | |
Cash | 136.2M | 101.4M | 122.2M | 81.6M | 193.2M | 104.9M | |
Capital Surpluse | 1.8M | 171.3M | 175.8M | 270.1M | 310.6M | 326.2M | |
Total Liab | 3.1M | 5.2M | 8.4M | 12.4M | 17.5M | 10.5M | |
Net Invested Capital | 138.3M | 109.5M | 118.0M | 104.5M | 236.2M | 248.0M | |
Total Current Assets | 140.6M | 113.5M | 124.5M | 108.8M | 244.5M | 256.7M | |
Net Working Capital | 137.4M | 108.4M | 116.2M | 99.3M | 228.5M | 239.9M | |
Other Assets | 101K | 299.0 | 357K | 565K | 1.0 | 0.95 | |
Other Current Assets | 4.3M | 4.9M | 2.3M | 2.3M | 3.2M | 3.3M |
Cabaletta Bio Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket. The other reason investors look at the income statement is to determine what Cabaletta Bio's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Operating Income | (18.7M) | (33.8M) | (46.3M) | (54.1M) | (74.7M) | (70.9M) | |
Ebit | (18.7M) | (33.8M) | (46.3M) | (54.1M) | (74.7M) | (70.9M) | |
Research Development | 11.7M | 21.4M | 32.5M | 39.3M | 55.4M | 58.2M | |
Income Before Tax | (16.9M) | (33.3M) | (46.3M) | (53.0M) | (67.7M) | (64.3M) | |
Net Income | (15.1M) | (32.5M) | (45.5M) | (51.8M) | (67.7M) | (64.3M) | |
Net Interest Income | 1.7M | 494K | 24K | 1.2M | 7.0M | 7.3M | |
Interest Income | 1.7M | 494K | 24K | 1.2M | 7.0M | 7.3M | |
Ebitda | (18.6M) | (33.5M) | (45.6M) | (53.0M) | (73.2M) | (69.6M) | |
Income Tax Expense | (1.8M) | (848K) | (757K) | (1.2M) | (1.0M) | (1.1M) |
Cabaletta Bio Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Cabaletta Bio. It measures of how well Cabaletta is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Cabaletta Bio brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Cabaletta had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Cabaletta Bio has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change In Cash | 103.2M | (34.8M) | 20.8M | (40.6M) | 111.6M | 117.2M | |
Net Income | (16.9M) | (33.3M) | (46.3M) | (53.0M) | (67.7M) | (64.3M) | |
End Period Cash Flow | 136.2M | 101.4M | 122.2M | 81.6M | 193.2M | 104.9M | |
Change To Netincome | 2.3M | 4.5M | 5.9M | 6.9M | 6.2M | 4.7M | |
Free Cash Flow | (16.7M) | (27.4M) | (35.3M) | (48.8M) | (54.2M) | (51.5M) | |
Other Non Cash Items | (105.9M) | 119K | 62K | 2.8M | 2.9M | 3.1M |
Cabaletta Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cabaletta Bio's current stock value. Our valuation model uses many indicators to compare Cabaletta Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cabaletta Bio competition to find correlations between indicators driving Cabaletta Bio's intrinsic value. More Info.Cabaletta Bio is rated fourth in return on equity category among related companies. It is rated below average in return on asset category among related companies . At present, Cabaletta Bio's Return On Equity is projected to slightly decrease based on the last few years of reporting.Comparative valuation analysis is a catch-all model that can be used if you cannot value Cabaletta Bio by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Cabaletta Bio's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cabaletta Bio's earnings, one of the primary drivers of an investment's value.Cabaletta Bio Systematic Risk
Cabaletta Bio's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Cabaletta Bio volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Cabaletta Bio correlated with the market. If Beta is less than 0 Cabaletta Bio generally moves in the opposite direction as compared to the market. If Cabaletta Bio Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Cabaletta Bio is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Cabaletta Bio is generally in the same direction as the market. If Beta > 1 Cabaletta Bio moves generally in the same direction as, but more than the movement of the benchmark.
About Cabaletta Bio Financials
What exactly are Cabaletta Bio Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Cabaletta Bio's income statement, its balance sheet, and the statement of cash flows. Potential Cabaletta Bio investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Cabaletta Bio investors may use each financial statement separately, they are all related. The changes in Cabaletta Bio's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Cabaletta Bio's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze Cabaletta Bio Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Cabaletta Bio is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Cabaletta has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Cabaletta Bio's financials are consistent with your investment objective using the following steps:- Review Cabaletta Bio's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Cabaletta Bio's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Cabaletta Bio's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Cabaletta Bio's stock is overvalued or undervalued.
Today, most investors in Cabaletta Bio Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Cabaletta Bio's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Cabaletta Bio growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Cabaletta Bio April 23, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Cabaletta Bio help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Cabaletta Bio. We use our internally-developed statistical techniques to arrive at the intrinsic value of Cabaletta Bio based on widely used predictive technical indicators. In general, we focus on analyzing Cabaletta Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Cabaletta Bio's daily price indicators and compare them against related drivers.
Information Ratio | (0.16) | |||
Maximum Drawdown | 17.98 | |||
Value At Risk | (7.79) | |||
Potential Upside | 6.24 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cabaletta Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.Note that the Cabaletta Bio information on this page should be used as a complementary analysis to other Cabaletta Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Complementary Tools for Cabaletta Stock analysis
When running Cabaletta Bio's price analysis, check to measure Cabaletta Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cabaletta Bio is operating at the current time. Most of Cabaletta Bio's value examination focuses on studying past and present price action to predict the probability of Cabaletta Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cabaletta Bio's price. Additionally, you may evaluate how the addition of Cabaletta Bio to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Transaction History View history of all your transactions and understand their impact on performance | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Money Managers Screen money managers from public funds and ETFs managed around the world |
Is Cabaletta Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cabaletta Bio. If investors know Cabaletta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cabaletta Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.65) | Return On Assets (0.25) | Return On Equity (0.40) |
The market value of Cabaletta Bio is measured differently than its book value, which is the value of Cabaletta that is recorded on the company's balance sheet. Investors also form their own opinion of Cabaletta Bio's value that differs from its market value or its book value, called intrinsic value, which is Cabaletta Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cabaletta Bio's market value can be influenced by many factors that don't directly affect Cabaletta Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cabaletta Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cabaletta Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cabaletta Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.